Blackrock Neurotech – MoveAgain Brain-Computer Interface System
Professor Florian Solzbacher, Co-Founder, Chairman, and President of Blackrock Neurotech discusses the MoveAgain Brain-Computer Interface (BCI) System that the FDA has granted a Breakthrough Device designation. It utilizes an array (electrode) implanted in the brain, which decodes intended movement from neuronal activity in the brain. This game-changing portable BCI offers patients new possibilities for movement and independence, reducing their reliance on caregivers and helping them better engage with society and the world. Blackrock has been leading the market for BCI technology for 15 years, with more humans implanted with Blackrock technology than any other BCI platform. Their aim is to commercially release the MoveAgain BCI system in 2022.